Role of endothelin-1 in hypertension and vascular disease

American Journal of Hypertension

Volumn 14, Issue 6 II, 2001, Pages

  Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Atherosclerosis; Endothelin antagonists; Mineralocorticoid; Salt sensitivity; Vascular remodeling

Indexed keywords

ENDOTHELIN 1; VASOCONSTRICTOR AGENT;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENDOTHELIUM INJURY; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0034993096     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02074-x     Document Type: Conference Paper

References (85)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. The human endothelin family-3 structurally and pharmacologically distinct isopeptides predicted by 3 separate genes
3. Cloning and expression of a cDNA encoding an endothelin receptor
4. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
5. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
6. Endothelin: Potential role in hypertension and vascular hypertrophy
7. Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography
8. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
9. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice
10. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats
11. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats
12. Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy
13. A antagonist prevents blood pressure elevation and vascular hypertrophy of resistance arteries in aldosterone-infused rats
14. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats
15. Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency
16. Structure and function of small arteries in salt-induced hypertension - Effects of chronic endothelin-subtype-A-receptor blockade
17. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension
18. Vascular endothelin-1 gene expression and effect of an endothelin A receptor antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats
19. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats
20. Anti-hypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats
21. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats
22. Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats
23. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist
24. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats
25. Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar Kyoto rats
26. In vitro vascular reactivity to endothelin: A comparison between young and old normotensive and hypertensive rats
27. Endothelin-1 attenuates omega-3 fatty acid-induced apoptosis by inhibition of caspase 3
28. Apoptosis in aorta of deoxycorticosterone acetate salt hypertensive rats: Effect of endothelin receptor antagonism
29. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats
30. Role for endothelin-1 in angiotensin II-mediated hypertension
31. Angiotensin II increases tissue endothelin and induces vascular hypertrophy - Reversal by ETA-receptor antagonist
32. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats
33. Endothelin system-dependent cardiac remodeling in renovascular hypertension
34. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms
35. A endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats
36. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage
37. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats
38. Effect of VI vasopressin antagonism on small artery structure and vascular expression of preproendothelin-1 in DOCA-salt hypertensive rats
39. Blood pressure, resistance artery structure and mechanics in DOCA-salt-treated vasopressindeficient Brattleboro rats. Role of endothelin
40. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells
41. Endothelin is a potent mitogen for rat vascular smooth muscle cells
42. Growth factor activity of endothelin on vascular smooth muscle
43. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: Correlation with vascular structure
44. Effects of endothelin receptor inhibition on cerebral arterioles in hypertensive rats
45. Vascular endothelin-1 gene expression and effect of an endothelin A receptor antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats
46. Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats
47. Endothelin A receptor blockade improves renal function and doubles the life-span of stroke-prone hypertensive rats
48. Cardiac fibrosis and inflammation: Interaction with hemodynamic and hormonal factors
49. A receptor antagonism
50. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat
51. Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats
52. Pressure enhances endothelin-1 release from cultured human endothelial cells
53. Clinical significance of endothelin in cardiovascular disease
54. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats - Comparison with angiotensin-converting enzyme inhibition and calcium antagonism
55. A receptor antagonism
56. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension
57. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects
58. Plasma immunoreactive endothelin in essential hypertension
59. Plasma endothelin in human essential hypertension
60. Regulation of plasma endothelin by salt in salt-sensitive hypertension
61. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans
62. Role of endothelin in the increased vascular tone of patients with essential hypertension
63. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients
64. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1
65. Enhanced expression of endothelin-1 gene in endothelium of resistance arteries in severe human essential hypertension
66. Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo
67. The atherogenic potential of endothelin
68. Endothelial control of the cardiovascular system: Recent advances
69. Elevated endothelin levels in patients with hyperlipoproteinemia
70. Elevated endothelin-1 levels after cigarette smoking
71. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans
72. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
73. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: A detailed analysis of the cellular distribution of endothelin-1
74. Endothelin-like immunoreactivity in atherosclerotic human coronary arteries
75. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis
76. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis
77. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries
78. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta
79. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages
80. A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
81. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol
82. Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration
83. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells
84. Hypertension-induced end-organ damage - A new transgenic approach to an old problem
85. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells